Karin Smyth

Karin Smyth

Labour — Bristol South

Speaking in the House of Commons on 23 October 2025

Debate

NHS Workforce Levels: Impact on Cancer Patients

Contribution

I do not have those numbers to hand but, as we outlined in the 10-year health plan, we are particularly committed to people in rural and coastal communities with regard to workforce and access to many other services. If there is anything specific the hon. Gentleman is not aware of, I am happy to furnish him with more information. We are, however, minded to rectify the variability across the country, even within towns and cities, let alone rural and coastal communities, whether that be in the north, south, east or west. We will ensure that ongoing investment in practice education continues to enhance clinical supervision, education and training across cancer and diagnostic workforces. That will increase placement capacity, support staff retention and contribute to high-quality patient care. We will not only ensure that the cancer workforce have the numbers to succeed, but also the skillset. Training academies in imaging, endoscopy and genomics are all being delivered across regions to provide intensive skills development and to support new models of care. We will also ensure that staff have the skills to adopt the treatments needed by cancer patients. Adoption of innovative cancer treatments is often clinician-led and self-identified, with doctors seeking out specialist training opportunities themselves. This may include overseas fellowships or short courses, after which skills are cascaded locally through continued professional development, multidisciplinary teams and peer-to-peer learning. The complex challenge of tackling the cancer and workforce issues we face will not be solved with a single solution, which is why the Department will be publishing a national cancer plan in the new year. The plan will have patients at its heart and will cover the entirety of the cancer pathway from referral and diagnosis to treatment and ongoing care, as well as prevention, research and innovation. The national cancer plan will build on the progress of the 10-year health plan to improve survival rates and reduce the number of lives lost to the biggest killers. On 4 February, we launched a call for evidence on the national cancer plan, which closed on 29 April. We received over 11,000 responses from individuals, professionals and organisations who shared their views on how we can do more to achieve our ambition. We have worked with crucial industry figures in the development of the national cancer plan, including the Royal College of Radiologists. The submissions are being used to inform our plan to improve cancer care. As I said, the Under-Secretary of State for Health and Social Care, my hon. Friend the Member for West Lancashire, is working hard on that issue. I thank the hon. Member for North Shropshire (Helen Morgan) for her recognition of the improvements being made at Shrewsbury and Telford and for her contribution, and that of other local MPs, in supporting that trust. Those are very welcome improvements. On research, the life sciences sector is critical to this Government’s growth mission and we want to make this country the best place to do life sciences. Of course, the Department is working closely with colleagues in the Department for Science, Innovation and Technology, the Department for Business and Trade, and His Majesty’s Treasury to make that happen. Finally, through this Government’s action on workforce and cancer capacity, we will ensure the NHS has the staff it needs to treat cancer patients safely across the country. I thank the hon. Member for Wokingham for securing this debate.

More from Karin Smyth

Other recent Hansard contributions by the same speaker.

About Hansard

Hansard is the official verbatim record of proceedings in the UK Parliament. Every word spoken in the Commons and Lords is recorded and published — this page is a single contribution from that record.

For Karin Smyth's full parliamentary record including voting history, expenses and all other contributions, see the Karin Smyth report card.

Partner sites